Lab-cultured cardiac cells

Three types of human heart cells have been grown from cultures derived from embryonic stem cells, by a team of Canadian, US and UK scientists.

During the research, when a mix of the cells was transplanted into mice with simulated heart disease, the animals’ heart function was significantly improved, according to research published in the journal Nature.
The embryonic stem cell cultures were carefully supplied with a staged cocktail of growth factors and other molecules involved in development, and grew into immature versions of cardiomyocytes, endothelial cells and vascular smooth muscle cells, each important constituents of heart muscle. ‘This development means that we can efficiently and accurately make different types of human heart cells for use in both basic and clinical research, said researcher Dr Gordon Keller, of the McEwen Centre for Regenerative Medicine in Toronto. ‘The immediate impact of this is significant, as we now have an unlimited supply of these cells to study how they develop, how they function and how they respond to different drugs. In the future, the cells may also be very effective in developing new strategies for repairing damaged hearts, following a heart attack.’

30.04.2008

More on the subject:

Related articles

Photo

News • Rapid diagnostics

New system simultaneously detects antibiotic resistence and virulence of K. pneumoniae

Now, a research team has developed a novel diagnostic approach that enables the rapid and simultaneous detection of both antibiotic resistance and high virulence in Klebsiella pneumoniae.

Photo

News • When good bacteria fight back

Klebsiella strain to protect against IBD gut infections

New research shows that a harmless strain of Klebsiella – discovered by chance in laboratory experiments – can eliminate infections and reduce gut inflammation in inflammatory bowel disease (IBD).

Photo

News • Standardized assessment criteria

Lost in translation: ICU experts call for universal severity score

Current scores to assess the severity of illness in ICU patients often fail in international contexts. Researchers now call for a global scoring system based on universally available data.

Related products

Subscribe to Newsletter